Europe — EMA
Orfiril Long (Sodium Valproate)
Sodium Valproate, the active ingredient in Orfiril Long, is an anticonvulsant presented as a oral tablet for systemic use. It treats epilepsy and related seizure disorders in adults and children.
Request sourcing
What is Sodium Valproate?
Sodium Valproate, the active ingredient in Orfiril Long, is an anticonvulsant presented as a oral tablet for systemic use. It treats epilepsy and related seizure disorders in adults and children. GNH USA supplies Orfiril Long as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Orfiril Long as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Sodium Valproate used for?
Orfiril Long is an antiepileptic drug that is used in the management of seizure disorders.
- Generalized tonic‑clonic seizures: Reduces the frequency and severity of these large bilateral seizures. - Absence seizures: Helps the short‑lasting absence episodes by stabilising neuronal activity. - Myoclonic seizures : St - ...
What are the side effects of Sodium Valproate?
Common Side Effects: - ... - ....
What precautions apply to Sodium Valproate?
Intro ...
What does Sodium Valproate interact with?
Major ....
